The U.S. Food and Drug Administration has approved Tremfya (guselkumab) for adult patients with moderately to severely active ...
Daily Voice on MSN7h
Kyler Robertson Of Edison Dies, 31Kyler Robertson, an Edison resident, died on Thursday, March 20 at the age of 31 from kidney failure, according to his ...
A plant-based diet made up of mainly nutrient-dense plant foods, or an equally healthy omnivorous diet may help reduce the ...
The Food and Drug Administration (FDA) has approved Tremfya ® (guselkumab) for the treatment of adults with moderately to severely active Crohn disease (CD).
A new study suggests AI can predict premature death among people who have inflammatory bowel disease, also known as Crohn's ...
A team of scientists has discovered mechanisms of abnormal immune cell function that may lead to Crohn’s disease, an ...
The gut microbiome and diet are important factors in the pathogenesis and management of Crohn's disease (CD). However, the role of the gut phageome under dietary influences is unknown.We aim to ...
A team of scientists has discovered mechanisms of abnormal immune cell function that may lead to Crohn’s disease, an ...
New study shows that dysfunction of protective immune cells in GI tract may contribute to onset of inflammation in Crohn's disease.
A research team led by Mount Sinai has uncovered mechanisms of abnormal immune cell function that may lead to Crohn's disease ...
HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) has announced that the U.S. Food and Drug Administration (FDA) has approved ...
The FDA has approved guselkumab (Tremfya) as the first IL-23 inhibitor offering both subcutaneous and intravenous induction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback